08
October 2024
Past Event
Do Drug Patents Cause High Drug Prices?

Event will air on this page.

 

Inquiries: msnow@hudson.org

Do Drug Patents Cause High Drug Prices?

Past Event
Online Only
October 08, 2024
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
Caption
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
08
October 2024
Past Event

Event will air on this page.

 

Inquiries: msnow@hudson.org

Speakers:
Adam Mossoff
Adam Mossoff

Chair, Forum for Intellectual Property and Senior Fellow

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law
Erika Lietzan

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law

Vice President and Global Head of Intellectual Property Affairs, Novartis
Corey A. Salsberg

Vice President and Global Head of Intellectual Property Affairs, Novartis

Moderator:
hartline
Devlin Hartline

Senior Fellow

For the past decade, policy activists have argued that drug innovators artificially extend the length of their exclusive patent protections on their drugs solely to keep drug prices high. One activist organization, the Initiative for Medicines, Access, and Knowledge (I-MAK), alleges that as many as 50 patents currently protect drugs from generic competition. 

But are I-MAK’s patent numbers correct? A 2022 Hudson policy memo, “How Unreliable Data Has Infected the Policy Debate Over Drug Patents,”detailed how I-MAK’s patent numbers contradict the number of drug patents listed in the Orange Book, the Food and Drug Administration’s official database of drug patents. Academic scholars have also done rigorous empirical studies, and the United States Patent and Trademark Office (USPTO) released its own empirical study in June 2024. Neither the USPTO nor the academic studies could replicate or confirm activist organizations’ patent numbers. Yet I-MAK’s claims continue to drive legislative proposals and agency actions.

Join Hudson for an expert discussion on the state of play concerning the empirical evidence on the connection between drug patents and drug prices and whether officials are engaging in evidence-based policymaking on this pressing concern.

Related Events
05
December 2025
In-Person Event | Hudson Institute
Moldova’s Euro-Atlantic Path: Regional Security, Energy Opportunity, and Democratic Resilience
Featured Speakers:
Mihai Popșoi
Igor Grosu
Leah Kieff
Moderator:
Luke Coffey
Getty Images
05
December 2025
In-Person Event | Hudson Institute
Moldova’s Euro-Atlantic Path: Regional Security, Energy Opportunity, and Democratic Resilience

Hudson’s Luke Coffey will host Moldovan Deputy Prime Minister and Minister of Foreign Affairs Mihai Popșoi, Speaker of the Moldovan Parliament Igor Grosu, and Center for Strategic and International Studies Senior Associate Leah Kieff to examine the current political, security, and geopolitical situation in Moldova and the region going forward.

Getty Images
Featured Speakers:
Mihai Popșoi
Igor Grosu
Leah Kieff
Moderator:
Luke Coffey
09
December 2025
In-Person Event | Hudson Institute
America’s Competitive Edge: Antitrust, Standards, and Intellectual Property for US Tech Leadership
Featured Speakers:
Dina Kallay
Urška Petrovčič
Getty Images
09
December 2025
In-Person Event | Hudson Institute
America’s Competitive Edge: Antitrust, Standards, and Intellectual Property for US Tech Leadership

Hudson will host an exclusive luncheon conversation with Dina Kallay, deputy assistant attorney general for international, policy and appellate at the Antitrust Division of the US Department of Justice. 

Getty Images
Featured Speakers:
Dina Kallay
Urška Petrovčič
11
December 2025
In-Person Event | Hudson Institute
Crowding in Capital: Modernizing the Department of War’s Financial Arsenal
Featured Speakers:
Rush Doshi
David Rader
Moderator:
Nadia Schadlow
Getty Images
11
December 2025
In-Person Event | Hudson Institute
Crowding in Capital: Modernizing the Department of War’s Financial Arsenal

Join Senior Fellow Nadia Schadlow and an expert panel for a discussion on the DoW’s financial tools, the extent of the department’s authorities, and the role it will play in the broader American reindustrialization effort.

Getty Images
Featured Speakers:
Rush Doshi
David Rader
Moderator:
Nadia Schadlow
12
December 2025
In-Person Event | Invite Only
Antisemitism as a National Security Threat
Featured Speakers:
Michael Doran
Bernard Haykel
Rebeccah L. Heinrichs
Can Kasapoğlu
Liel Leibovitz
Michael Sobolik
Getty Images
12
December 2025
In-Person Event | Invite Only
Antisemitism as a National Security Threat

Hudson’s Center for Peace and Security in the Middle East will convene policymakers, experts, and private sector leaders to examine how antisemitism, both foreign and domestic, threatens American security and Western civilization.

Getty Images
Featured Speakers:
Michael Doran
Bernard Haykel
Rebeccah L. Heinrichs
Can Kasapoğlu
Liel Leibovitz
Michael Sobolik